These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21492094)

  • 1. Pharmacological interventions for binge eating: lessons from animal models, current treatments, and future directions.
    Berner LA; Bocarsly ME; Hoebel BG; Avena NM
    Curr Pharm Des; 2011; 17(12):1180-7. PubMed ID: 21492094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binge eating in pre-clinical models.
    Rospond B; Szpigiel J; Sadakierska-Chudy A; Filip M
    Pharmacol Rep; 2015 Jun; 67(3):504-12. PubMed ID: 25933962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of binge-eating disorder: a review.
    Goracci A; di Volo S; Casamassima F; Bolognesi S; Benbow J; Fagiolini A
    J Addict Med; 2015; 9(1):1-19. PubMed ID: 25629881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions.
    Grilo CM; Reas DL; Mitchell JE
    Curr Psychiatry Rep; 2016 Jun; 18(6):55. PubMed ID: 27086316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological approaches in the treatment of binge eating disorder.
    Appolinario JC; McElroy SL
    Curr Drug Targets; 2004 Apr; 5(3):301-7. PubMed ID: 15058314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacologic treatment of eating disorders: emerging findings.
    McElroy SL; Guerdjikova AI; Mori N; Keck PE
    Curr Psychiatry Rep; 2015 May; 17(5):35. PubMed ID: 25796197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of binge eating disorder: update review and synthesis.
    Reas DL; Grilo CM
    Expert Opin Pharmacother; 2015; 16(10):1463-78. PubMed ID: 26044518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder.
    Heal DJ; Hallam M; Prow M; Gosden J; Cheetham S; Choi YK; Tarazi F; Hutson P
    J Psychopharmacol; 2017 Jun; 31(6):770-783. PubMed ID: 28376679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of orlistat in obese patients with binge eating disorder.
    Golay A; Laurent-Jaccard A; Habicht F; Gachoud JP; Chabloz M; Kammer A; Schutz Y
    Obes Res; 2005 Oct; 13(10):1701-8. PubMed ID: 16286517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological approaches to the management of binge eating disorder.
    Brownley KA; Peat CM; La Via M; Bulik CM
    Drugs; 2015 Jan; 75(1):9-32. PubMed ID: 25428709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAergic and glutamatergic modulation in binge eating: therapeutic approach.
    Guardia D; Rolland B; Karila L; Cottencin O
    Curr Pharm Des; 2011; 17(14):1396-409. PubMed ID: 21524265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of bulimia nervosa and binge eating disorder.
    Walsh BT; Devlin MJ
    Addict Behav; 1995; 20(6):757-64. PubMed ID: 8820528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting meaningful outcomes to medication and self-help treatments for binge-eating disorder in primary care: The significance of early rapid response.
    Grilo CM; White MA; Masheb RM; Gueorguieva R
    J Consult Clin Psychol; 2015 Apr; 83(2):387-94. PubMed ID: 25622201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Would glucagon-like peptide-1 receptor agonists have efficacy in binge eating disorder and bulimia nervosa? A review of the current literature.
    McElroy SL; Mori N; Guerdjikova AI; Keck PE
    Med Hypotheses; 2018 Feb; 111():90-93. PubMed ID: 29407005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing comorbid obesity and depression through clinical pharmacotherapies.
    McElroy SL; Guerdjikova AI; Mori N; Keck PE
    Expert Opin Pharmacother; 2016 Aug; 17(12):1599-610. PubMed ID: 27280311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate use in obese patients with binge eating disorder: an open study.
    Appolinario JC; Fontenelle LF; Papelbaum M; Bueno JR; Coutinho W
    Can J Psychiatry; 2002 Apr; 47(3):271-3. PubMed ID: 11987480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.
    McElroy SL; Guerdjikova AI; Blom TJ; Crow SJ; Memisoglu A; Silverman BL; Ehrich EW
    Int J Eat Disord; 2013 Apr; 46(3):239-45. PubMed ID: 23381803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Academy for Eating Disorders International Conference on Eating Disorders. Denver, CO, USA, May 29-31, 2003.
    Kaplan AS
    Expert Opin Investig Drugs; 2003 Aug; 12(8):1441-3. PubMed ID: 12882630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study.
    Guerdjikova AI; Walsh B; Shan K; Halseth AE; Dunayevich E; McElroy SL
    Adv Ther; 2017 Oct; 34(10):2307-2315. PubMed ID: 28918581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.